.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Farmers Insurance
McKinsey
Colorcon
Argus Health
McKesson
Cantor Fitzgerald
Accenture
Queensland Health
UBS

Generated: December 13, 2017

DrugPatentWatch Database Preview

ZAXOPAM Drug Profile

« Back to Dashboard

When do Zaxopam patents expire, and when can generic versions of Zaxopam launch?

Zaxopam is a drug marketed by Quantum Pharmics and is included in three NDAs.

The generic ingredient in ZAXOPAM is oxazepam. There are eight drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the oxazepam profile page.
Drug patent expirations by year for ZAXOPAM

Medical Subject Heading (MeSH) Categories for ZAXOPAM

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Quantum PharmicsZAXOPAMoxazepamCAPSULE;ORAL070650-001Mar 1, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Quantum PharmicsZAXOPAMoxazepamCAPSULE;ORAL070640-001Mar 1, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Quantum PharmicsZAXOPAMoxazepamCAPSULE;ORAL070641-001Mar 1, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
QuintilesIMS
Novartis
Farmers Insurance
Accenture
Cantor Fitzgerald
US Department of Justice
Colorcon
Chubb
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot